BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 24342706)

  • 1. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
    Cho SI; Lee CH; Park GH; Park CW; Kim HO
    J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex regional pain syndrome-like symptoms during herpes zoster.
    Berry JD; Rowbotham MC; Petersen KL
    Pain; 2004 Jul; 110(1-2):e1-12. PubMed ID: 15275746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster.
    Katz J; McDermott MP; Cooper EM; Walther RR; Sweeney EW; Dworkin RH
    J Pain; 2005 Dec; 6(12):782-90. PubMed ID: 16326366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-band ultraviolet B phototherapy in zoster patients may reduce the incidence and severity of postherpetic neuralgia.
    Jalali MH; Ansarin H; Soltani-Arabshahi R
    Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):232-7. PubMed ID: 16948824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study.
    Opstelten W; Zuithoff NPA; van Essen GA; van Loon AM; van Wijck AJM; Kalkman CJ; Verheij TJM; Moons KGM
    Pain; 2007 Nov; 132 Suppl 1():S52-S59. PubMed ID: 17379412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of pain following herpes zoster.
    Thyregod HG; Rowbotham MC; Peters M; Possehn J; Berro M; Petersen KL
    Pain; 2007 Mar; 128(1-2):148-56. PubMed ID: 17070998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?
    Coen PG; Scott F; Leedham-Green M; Nia T; Jamil A; Johnson RW; Breuer J
    Eur J Pain; 2006 Nov; 10(8):695-700. PubMed ID: 16427792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for postherpetic neuralgia in patients with herpes zoster.
    Jung BF; Johnson RW; Griffin DR; Dworkin RH
    Neurology; 2004 May; 62(9):1545-51. PubMed ID: 15136679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster.
    Kurokawa I; Murakawa K; Kumano K
    Int J Clin Pract; 2007 Jul; 61(7):1223-9. PubMed ID: 17362479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster and postherpetic neuralgia in older adults.
    Schmader K
    Clin Geriatr Med; 2007 Aug; 23(3):615-32, vii-viii. PubMed ID: 17631237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster.
    Sato-Takeda M; Ihn H; Ohashi J; Tsuchiya N; Satake M; Arita H; Tamaki K; Hanaoka K; Tokunaga K; Yabe T
    Pain; 2004 Jul; 110(1-2):329-36. PubMed ID: 15275783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postherpetic neuralgia with varicella-zoster hyperimmune globulin.
    Hügler P; Siebrecht P; Hoffmann K; Stücker M; Windeler J; Altmeyer P; Laubenthal H
    Eur J Pain; 2002; 6(6):435-45. PubMed ID: 12413432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate evidence for a revised definition of postherpetic neuralgia (PHN).
    Dworkin RH
    Pain; 2007 Mar; 128(1-2):189-90; author reply 190-2. PubMed ID: 17240068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuralgia and zovirax treatment of patients with herpes zoster].
    Dekonenko EP; Shishov AS; Kupriianova LV; Rudometov IuP; Bagrov FI
    Ter Arkh; 1998; 70(12):63-5. PubMed ID: 10067257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROCESS Trial: Effect of Duloxetine Premedication for Postherpetic Neuralgia Within 72 Hours of Herpes Zoster Reactivation-A Randomized Controlled Trial.
    Zhao C; Zhang T; Zhu Q; Chen Z; Ren H; Shrestha N; Meng L; Shen Y; Luo F
    Clin Infect Dis; 2024 Apr; 78(4):880-888. PubMed ID: 38015658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster.
    Kanai A; Osawa S; Suzuki A; Ishimaru R; Hoka S
    Pain Med; 2007; 8(1):36-40. PubMed ID: 17244102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and management of postherpetic neuralgia.
    Gershon AA
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):8-13. PubMed ID: 8840411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute herpetic and postherpetic neuralgia: clinical review and current management.
    Portenoy RK; Duma C; Foley KM
    Ann Neurol; 1986 Dec; 20(6):651-64. PubMed ID: 3545049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management strategies for herpes zoster and postherpetic neuralgia.
    Galluzzi KE
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S8-S13. PubMed ID: 17488885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.